tiprankstipranks
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF
US Market
Holding IPHYF?
Track your performance easily

Innate Pharma SA (IPHYF) Dividend Date & History

27 Followers
Innate Pharma SA (IPHYF) has no upcoming dividends

Other Large Cap Stocks Paying Dividends

Name
Dividend Yield
Smart Score
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Follow
MO
Altria Group
$3.998 (7.6%)
$89.15B
8.88
30.15%
4 Buy
3 Hold
2 Sell
Hold
T
AT&T
$1.108 (4.55%)
$175.08B
16.36
38.22%
18 Buy
4 Hold
0 Sell
Strong Buy
XRX
Xerox
$1 (10.93%)
$1.14B
-0.80
-54.75%
0 Buy
1 Hold
1 Sell
Moderate Sell
IBM
International Business Machines
$6.666 (2.96%)
$208.66B
32.84
21.70%
5 Buy
6 Hold
1 Sell
Moderate Buy
CVX
Chevron
$6.52 (4.17%)
$280.72B
17.19
3.71%
16 Buy
3 Hold
0 Sell
Strong Buy
EOG
EOG Resources
$3.705 (3.95%)
$73.26B
10.49
11.52%
11 Buy
12 Hold
0 Sell
Moderate Buy
ET
Energy Transfer
$1.282 (6.27%)
$69.68B
14.98
41.00%
9 Buy
1 Hold
0 Sell
Strong Buy
HESM
Hess Midstream Partners
$2.703 (6.46%)
$8.91B
17.30
22.14%
1 Buy
1 Hold
0 Sell
Moderate Buy
ARCC
Ares Capital
$1.916 (8.16%)
$15.21B
9.03
12.47%
7 Buy
2 Hold
0 Sell
Strong Buy

FAQ

Does Innate Pharma SA pay dividends?
No, Innate Pharma SA (IPHYF) has not paid a dividend within the past 12 months.
    How much is Innate Pharma SA's dividend?
    Innate Pharma SA (IPHYF) does not pay a dividend
    When is Innate Pharma SA ex-dividend date?
    Innate Pharma SA (IPHYF) does not pay a dividend.
    When is Innate Pharma SA dividend payment date?
    Innate Pharma SA (IPHYF) does not pay a dividend.
    Does Innate Pharma SA have sufficient earnings to cover their dividend?
    The Innate Pharma SA has paid a dividend in the last year and may provide dividends in the near future.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis